Want to track NAGE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Niagen Bioscience Inc. (NAGE) Statistics
Valuation metrics
Market Cap -
Enterprise value 149.83M
Trailing P/E (ttm) 13.85
Forward P/E -
PEG ratio -0.8
Price/Sales (ttm) 1.66
Price/Book (mrq) 2.59
Enterprise Value/Revenue 1.16
Enterprise Value/EBITDA 8.18
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 268.1K
Average volume (90 days) 604.33K
Price summary
52-Week low 2.46
52-Week high 7.95
Beta -
50-Day moving average 2.93
200-Day moving average 4.1
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:3
Last split Date 13 Apr 2016
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.12%
Operating margin 0.07%
Operational effectiveness
Return on assets 0.15%
Return on equity 0.2%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.63
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.2
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.84
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 6.5%
Book value per share (mrq) 1.04
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
